Expression of a human multidrug resistance gene in human ovarian carcinoma cell lines

Lab / animal OA: closed
View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-09-19 ⓘ

Researchers analyzed mdr 1 expression in eight human ovarian adenocarcinoma cell lines, finding that mRNA transcripts were present only in the most resistant line without DNA amplification, suggesting mdr 1 contributes to chemoresistance.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

To investigate the possible role of the multidrug resistance phenotype to chemoresistance in human ovarian carcinoma, we have analyzed human multidrug resistance gene (mdr 1) expression in 8 human ovarian adenocarcinoma cell lines. An increase in P-glycoprotein level specific to multidrug-resistant tumor cells was not apparently associated with the increase in resistance to vincristine (VCR) or doxorubicin (Adriamycin). Mdr 1 transcripts (4.5 kilobases) were observed in the RNA preparation obtained from only one cell line (SHIN-3) that showed the highest resistance to both drugs in vitro and in vivo. No cell lines showed mdr 1 DNA amplification. These results suggest that the insensitivity of human ovarian carcinoma to chemotherapy could be partly explained by the expression of mdr 1.

My notes (saved in your browser only)

MeSH descriptors

Gene Expression Regulation, Neoplastic Membrane Glycoproteins Ovarian Neoplasms Adenocarcinoma Adenocarcinoma Adenocarcinoma Adenocarcinoma ATP Binding Cassette Transporter, Subfamily B, Member 1 Cell Division Cell Division Cell Line Cystadenocarcinoma Cystadenocarcinoma Cystadenocarcinoma Cystadenocarcinoma Doxorubicin Doxorubicin Endometriosis Endometriosis Endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-10-11T09:27:45.537177+00:00
pubmed
last seen: 2026-10-08T21:01:33.631068+00:00